Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism

Journal of Human Hypertension volume 28, pages 298–302 (2014)Cite this article

Subjects

Abstract

We hypothesized aldosteronoma responsiveness to cosyntropin may be a characterizing feature that could be determined in addition to standard adrenal vein sampling (AVS) data. We reviewed an AVS database from June 2005 to October 2011 including 65 patients with confirmed primary aldosteronism (PA) who underwent AVS and, if applicable, unilateral adrenalectomy. Patients were divided into confirmed lateralized and non-lateralized groups and subgrouped by histology. Plasma aldosterone in inferior vena cava (IVC) pre- and post-cosyntropin infusion during AVS was measured. Peak aldosterone and proportional change was compared between groups. Baseline and peak IVC aldosterone was higher in lateralized patients but incremental aldosterone rise was much greater in subjects with bilateral hyperplasia. From receiver operator characteristics (ROC) analysis, the optimized diagnostic cut point of peak IVC aldosterone of >649 pmol l−1 would have a sensitivity of 94% for surgical disease although specificity of just 59%. A 250% increase in IVC aldosterone following cosyntropin would be specific enough to exclude 87% of surgical/lateralized disease. These diagnostic capabilities are similar to other results with non-AVS tests performed for diagnosis of lateralization. Although not specific enough to replace standard AVS interpretation, a marked IVC aldosterone increase after cosyntropin during AVS is a useful additional test to diagnose non-lateralizing forms of PA. Such a calculation requires no additional expense or tests.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Mulatero P, Stowasser M, Loh K, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045–1050.

    Article  CAS  Google Scholar 

  2. Nishikawa T, Saito J, Omura M . Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocrine J 2007; 54: 487–495.

    Article  CAS  Google Scholar 

  3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al. A prospective study of the prevalence of primary aldsteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293–2300.

    Article  CAS  Google Scholar 

  4. Tresallet CT, Salepcioglu H, Godiris-Petit G, Hoang C, Girerd X, Menegaux F . Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery 2010; 148: 129–134.

    Article  Google Scholar 

  5. Hennings J, Andreasson S, Botling J, Hagg A, Sundin A, Hellman P . Longterm effects of surgical corrections of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbecks Arch Surg 2010; 395: 133–137.

    Article  CAS  Google Scholar 

  6. Graham UM, Ellist PK, Hunter SJ, Leslie H, Mullan KR, Atkinson AB . cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes. Clin Endocrinology 2012; 76: 26–32.

    Article  CAS  Google Scholar 

  7. Waldman J, Maurer L, Holler J, Kann PH, Ramaswamy A, Bartsch DK et al. Outcome of surgery for primary hyperaldosteronism. World J Surg 2011; 35: 2422–2427.

    Article  Google Scholar 

  8. Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S et al. Single center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. Urology 2011; 78: 68–73.

    Article  Google Scholar 

  9. Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF . Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008; 26: 1816–1823.

    Article  CAS  Google Scholar 

  10. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001; 86: 1066–1071.

    CAS  PubMed  Google Scholar 

  11. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266–3281.

    Article  CAS  Google Scholar 

  12. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D et al. The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 2012; 97: 1606–1614.

    Article  CAS  Google Scholar 

  13. Rossi GP . New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep 2007; 9: 90–97.

    Article  CAS  Google Scholar 

  14. Mulatero P, Bertello C, Sukor N, Gordon R, Rossato D, Daunt N et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 2010; 55: 667–673.

    Article  CAS  Google Scholar 

  15. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D . Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008; 26: 989–997.

    Article  CAS  Google Scholar 

  16. Kline GA, Harvey A, Jones C, Hill MD, So B, Scott-Douglas N et al. Adrenal vein sampling in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Int Urol Nephrol 2008; 40: 1035–1043.

    Article  CAS  Google Scholar 

  17. Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV et al. Evaluation of the sensitivity and specificity of 11C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by conn’s adenomas. J Clin Endocrinol Metab 2012; 97: 100–109.

    Article  CAS  Google Scholar 

  18. Mulatero P, Morra di Cella S, Monticone S, Schiavone D, Manzo M, Mengozzi G et al. 18-Hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab 2012; 97: 881–889.

    Article  CAS  Google Scholar 

  19. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG . Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1997; 82 (11): 3570–3573.

    CAS  PubMed  Google Scholar 

  20. Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C et al. Roles of clinical criteria, computed tomography scan and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 2008; 93: 1366–1371.

    Article  CAS  Google Scholar 

  21. Alvarez-Madrazo S, Padmanabhan S, Mavosi BM, Watkins H, Avery P, Wallace AM et al. Familial and phenotypic associations of the aldosterone-renin ratio. J Clin Endocrinol Metab 2009; 94 (11): 4324–4333.

    Article  CAS  Google Scholar 

  22. Montori VM, Young WF . Use of plasma aldosterone concentration to plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin N Am 2002; 31: 619–632.

    Article  CAS  Google Scholar 

  23. Lau JHG, Candy Sze WC, Reznek RH, Matson M, Sahdav A, Carpenter R et al. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin Endocrinol 2012; 76: 182–188.

    Article  CAS  Google Scholar 

  24. Nakamura Y, Satoh F, Morimoto R, Kudo M, Takase K, Gomez-Sanchez CE et al. 18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab 2011; 96: E1271–E1278.

    Article  Google Scholar 

  25. Kupers EM, Amar L, Raynaud A, Plouin PF, Steichen O . A clinical prediction score to diagnose unilateral primary aldosteronism. J Clin Endocrinol Metab 2012; 97 (10): 3530–3537.

    Article  CAS  Google Scholar 

  26. Sonoyama T, Sone M, Miyashita K, Tamura N, Yamahara K, Park K et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone producing adenoma. J Clin Endocrinol Metab 2011; 96: 2771–2778.

    Article  CAS  Google Scholar 

  27. Dluhy RG, Lifton RP . Glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 1999; 84: 4341–4344.

    Article  CAS  Google Scholar 

  28. Pizzolo F, Trabetti E, Guarini P, Mulatero P, Ciacciarelli A, Blengio GS et al. Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting. J Hum Hypertens 2005; 19: 325–327.

    Article  CAS  Google Scholar 

  29. Mulatero P, Tizzani D, Viola A, Bertello C, Monitcone S, Mengozzi G et al. Prevalence and characteristics of familial hyperaldosteronism. Hypertension 2011; 58: 797–803.

    Article  CAS  Google Scholar 

  30. Honour JW, Bridges NA, Conway-Phillips E, Hindmarsh PC . Plasma aldosterone response to the low dose adrenocorticotropin (ACTH 1-24) stimulation test. Clin Endocrinol 2007; 68: 299–303.

    Google Scholar 

  31. Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M . Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol 2009; 160: 443–451.

    Article  CAS  Google Scholar 

  32. Ye P, Mariniello B, Mantero F, Rainey WE . G-protein coupled receptors in aldosterone producing adenoma: a potential cause of hyperaldosteronism. J Endocrinol 2007; 195: 39–48.

    Article  CAS  Google Scholar 

  33. Lampron A, Bourdeau I, Oble S, Godbout A, Schurch W, Arjane P et al. Regulation of aldosterone secretion by several aberrant receptors including for glucose dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metab 2009; 94: 750–756.

    Article  CAS  Google Scholar 

  34. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A et al. Human adipocytes secrete mineralocorticoid releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211–14216.

    Article  CAS  Google Scholar 

  35. Goodfried TL, Ball DL, Raff H, Bruder ED, Gardner HW, Spiteller G . Oxidized products of linoleic acid stimulate adrenal steroidogenesis. Endocr Res 2002; 28: 325–330.

    Article  Google Scholar 

  36. Sonino N, Tomba E, Genesia ML, Bertello C, Mulatero P, Veglio F et al. Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab 2011; 96: E878–E883.

    Article  CAS  Google Scholar 

  37. Kubzansky LD, Adler GK . Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease. Neurosci Biobehav R 2010; 34: 80–86.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Endocrinology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

    G A Kline

  2. Department of Surgery, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

    J L Pasieka & A Harvey

  3. Department of Radiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

    B So

  4. Department of Clinical Biochemistry, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

    V C Dias

Authors
  1. G A Kline
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J L Pasieka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Harvey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B So
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V C Dias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G A Kline.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kline, G., Pasieka, J., Harvey, A. et al. A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism. J Hum Hypertens 28, 298–302 (2014). https://doi.org/10.1038/jhh.2013.116

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2013.116

Keywords

This article is cited by

Search

Advanced search

Quick links